专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明申请

WO2005082414A2 CONCOMITANT DRUGS 审中-公开
标题翻译：可持续药物
公开(公告)号：WO2005082414A2
公开(公告)日：2005-09-09
申请号：PCT/JP2005004022
申请日：2005-03-02
申请人： FUJISAWA PHARMACEUTICAL CO , KAYAKIRI HIROSHI , KATO TAKESHI , MINOURA HIDEAKI , HIROSUMI JIRO
发明人： KAYAKIRI HIROSHI , KATO TAKESHI , MINOURA HIDEAKI , HIROSUMI JIRO
IPC分类号： A61K31/18 , A61K45/06 , A61P3/00
CPC分类号： A61K45/06 , A61K31/18 , A61K2300/00
摘要： This invention provides a pharmaceutical agent containing, in combination, a sulfonamide compound and other therapeutic agent, preferably, at least one compound represented by the formula (I): R -SO2-NH-CO-A -CH2-R [each symbol is as defined in the specification] or a pharmaceutically acceptable salt thereof, and at least one pharmaceutical agent selected from the group consisting of an alpha-glucosidase inhibitor, an insulin secretagogue, a sulfonylurea and a biguanide, which has a superior therapeutic effect.
摘要翻译：本发明提供了一种药物，其组合含有磺酰胺化合物和其它治疗剂，优选至少一种由式（I）表示的化合物：R 1 -SO 2 -NH-CO-A 1 -CH 2 -R 2 [各符号如说明书中所定义]或其药学上可接受的盐，以及至少一种选自α-葡糖苷酶抑制剂，胰岛素促分泌素，磺酰脲和双胍的药剂，具有优越的治疗效果。

12. 发明申请

WO03100795A8 OXIDE SUPERCONDUCTING WIRE PRODUCING METHOD 审中-公开
标题翻译：氧化物超导线生产方法
公开(公告)号：WO03100795A8
公开(公告)日：2004-05-27
申请号：PCT/JP0306429
申请日：2003-05-22
申请人： SUMITOMO ELECTRIC INDUSTRIES , KOBAYASHI SHIN-ICHI , KATO TAKESHI
发明人： KOBAYASHI SHIN-ICHI , KATO TAKESHI
IPC分类号： H01B13/00 , H01L39/24 , H01R43/00
CPC分类号： H01L39/248 , Y10T29/49014 , Y10T29/49117 , Y10T29/49194 , Y10T29/49222
摘要： An oxide superconducting wire producing method comprising a step of producing a wire having a form in which the material powder of an oxide superconductor is covered with a metal (S1, S2) and a step of heat-treating the wire in a pressurized atmosphere (S4, S6), wherein the total pressure of the pressurized atmosphere lies in the range from 1 to 50 MPa. In such a way, voids among the oxide superconducting crystals and bulging of the oxide superconducting wire are prevented, and the partial pressure of oxygen during the heat treatment can be easily controlled, thereby improving the critical current density.
摘要翻译：一种氧化物超导线制造方法，包括以下步骤：制造具有氧化物超导体的材料粉末被金属（S1，S2）覆盖的形式的线材和在加压气氛中对线材进行热处理的步骤（S4 ，S6），其中加压气氛的总压力在1至50MPa的范围内。以这种方式，可以防止氧化物超导晶体中的空隙和氧化物超导线的膨胀，并且可以容易地控制热处理期间的氧分压，从而提高临界电流密度。

13. 发明申请

WO2003006437A1 IMIDAZOLE DERIVATIVES AS ADENOSINE DEAMINASE INHIBITORS 审中-公开
标题翻译：咪唑衍生物作为腺苷类杀虫剂抑制剂
公开(公告)号：WO2003006437A1
公开(公告)日：2003-01-23
申请号：PCT/JP2002/006983
申请日：2002-07-10
申请人： FUJISAWA PHARMACEUTICAL CO., LTD. , TERASAKA, Tadashi , KATO, Takeshi , TSUJI, Kiyoshi , NAKAMURA, Katsuya
发明人： TERASAKA, Tadashi , KATO, Takeshi , TSUJI, Kiyoshi , NAKAMURA, Katsuya
IPC分类号： C07D233/90
CPC分类号： C07D401/12 , C07D233/90 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
摘要： Imidazole compounds having adenosine deaminase inhibitory activity represented by the formula (I)wherein R1 is aryl or heterocyclic group which is optionally substituted with substituent(s);R 2 is lower alkyl;R 3 is hydroxy or protected hydroxy;- A - is lower alkylene; and- X - is - O - or - S -;provided that when - X - is - O -, then R 1 is aryl which is substituted with substituent(s), or heterocyclic group which is optionally substituted with substituent(s),its prodrug, or their salt. The compounds are useful for treating and/or preventing diseases for which adenosine is effective.
摘要翻译：具有式（I）表示的腺苷脱氨酶抑制活性的咪唑化合物，其中R 1为任选被取代基取代的芳基或杂环基; R 2为低级烷基; R 3为羟基或被保护的羟基; -A-为低级亚烷基; X - 为-O-或-S-;条件是当-X - 为-O-时，R 1为被取代基取代的芳基或任选被取代基取代的杂环基，其前药或其盐。该化合物可用于治疗和/或预防腺苷有效的疾病。

14. 发明申请

WO1993015041A1 ETHANOLAMINE DERIVATIVES HAVING SYMPATHOMIMETIC AND ANTI-POLLAKIURIA ACTIVITIES 审中-公开
标题翻译：具有反应性和抗肿瘤活性的乙酰胺衍生物
公开(公告)号：WO1993015041A1
公开(公告)日：1993-08-05
申请号：PCT/JP1993000113
申请日：1993-02-01
申请人： FUJISAWA PHARMACEUTICAL CO., LTD. , SHIOKAWA, Youichi , NAGANO, Masanobu , TANIGUCHI, Kiyoshi , TAKE, Kazuhiko , KATO, Takeshi , TSUBAKI, Kazunori
发明人： FUJISAWA PHARMACEUTICAL CO., LTD.
IPC分类号： C07C217/74
CPC分类号： C07C229/16 , C07C215/08 , C07C215/14 , C07C215/64 , C07C217/74 , C07C235/20 , C07C2602/12 , C07D213/61 , C07D271/12 , C07D317/58 , Y02P20/55
摘要： This invention relates to new ethanolamine derivatives having gut selective sympathomimetic and anti-pollakiuria activities and represented by general formula (I) wherein R is aryl or a heterocyclic group, each of which may be substituted with halogen, etc., R is hydrogen, halogen, nitro, hydroxy, lower alkyl optionally substituted with acyl, lower alkenyl optionally substituted with acyl, lower alkoxy optionally substituted with acyl, or amino optionally substituted with acyl(lower)alkyl, R is hydrogen, an N-protective group, or lower alkyl optionally substituted with lower alkylthio, n is an integer of 0 to 3, and a heavy solid line means a single bond or a double bond, provided that when n is 1, then 1) R is a condensed aromatic hydrocarbon group or a heterocyclic group, each of which may be substituted with halogen, etc., and the like, and pharmaceutically acceptable salts thereof to processes for the preparation thereof and to a pharmaceutical composition comprising the same.
摘要翻译：本发明涉及具有肠选择性交感神经兴奋和抗尿频活性的新型乙醇胺衍生物，其通式（I）表示，其中R 1为可被卤素取代的芳基或杂环基等。羟基，任选被酰基取代的低级烷基，任选被酰基取代的低级烯基，任选被酰基取代的低级烷氧基或任选被酰基（低级）烷基取代的氨基，R 3是氢， N-保护基或任选被低级烷硫基取代的低级烷基，n为0〜3的整数，重实线表示单键或双键，条件是当n为1时，则1）R' 1>是可以被卤素等取代的稠合芳香族烃基或杂环基等及其药学上可接受的盐，其制备方法和包含th的药物组合物同样的

15. 发明申请

WO1993002460A1 METHOD FOR MANUFACTURING SUPERCONDUCTIVE WIRE MATERIAL OF BISMUTH BASED OXIDE 审中-公开
标题翻译：基于二氧化硅的超导材料的制造方法
公开(公告)号：WO1993002460A1
公开(公告)日：1993-02-04
申请号：PCT/JP1992000935
申请日：1992-07-22
申请人： SUMITOMO ELECTRIC INDUSTRIES, LTD. , JAPAN as represented by DIRECTOR GENERAL OF NATI , RESEARCH DEVELOPMENT CORPORATION OF JAPAN , KATO, Takeshi , SATO, Kenichi
发明人： SUMITOMO ELECTRIC INDUSTRIES, LTD. , JAPAN as represented by DIRECTOR GENERAL OF NATI , RESEARCH DEVELOPMENT CORPORATION OF JAPAN
IPC分类号： H01B13/00
CPC分类号： H01L39/248 , Y10T29/49014
摘要： A manufacturing method wherein a metal sheath is filled with a powder having a composition such that the amounts of Sr, Ca and Cu are larger than conventional so that in addition to the 2223-phase of (Bi, Pb)-Sr-Ca-Cu the phase of Sr-Ca-Cu-O may be precipitated, and then, this metal sheath is subjected to a plastic working, a primary heat treatment, another plastic working, and a secondary heat treatment in this order. A pinning point based on the phase of Sr-Ca-Cu-O is introduced into the superconductor of the obtained bismuth based oxide superconductive wire material, and thereby, the magnetic field characteristic of the critical current density is improved.

16. 发明申请

WO1992018461A1 ETHANOLAMINE DERIVATIVES WITH ANTI-POLLAKIURIA ACTIVITY 审中-公开
标题翻译：具有抗肿瘤活性的乙酰胺衍生物
公开(公告)号：WO1992018461A1
公开(公告)日：1992-10-29
申请号：PCT/JP1992000449
申请日：1992-04-10
申请人： FUJISAWA PHARMACEUTICAL CO., LTD. , SHIOKAWA, Youichi , NAGANO, Masanobu , TANIGUCHI, Kiyoshi , TAKE Kazuhiko , KATO, Takeshi , TSUBAKI, Kazunori
发明人： FUJISAWA PHARMACEUTICAL CO., LTD.
IPC分类号： C07C217/74
CPC分类号： C07C255/59 , C07C217/74 , C07C317/32 , C07C2602/10
摘要： This invention relates to new ethanolamine derivatives having gut selective sympathomimetic and anti-pollakiuria activities and represented by general formula (I), wherein R is hydrogen or halogen, R is halogen, hydroxy, protected hydroxy, aryloxy, lower alkoxy, halo(lower)alkoxy, nitro, cyano, amino or acylamino, R is hydrogen or halogen, R is hydrogen or lower alkyl, R is hydrogen or lower alkyl, R is hydrogen, hydroxy or lower alkyl, R is hygrogen or lower alkyl, R is hydrogen or halogen, R is carboxy or esterified carboxy, and A is lower alkylene, provided that R is lower alkyl; R is lower alkyl; R is hydroxy or lower alkyl; or R is halogen when R is hydrogen, R is halogen and R is hydrogen, and pharmaceutically acceptable salts thereof, to processes for the preparation thereof and to a pharmaceutical composition comprising the same.
摘要翻译：本发明涉及具有肠选择性交感神经和抗血尿功能的新型乙醇胺衍生物，其通式（I）表示，其中R 1为氢或卤素，R 2为卤素，羟基，被保护的羟基，芳氧基，低级烷氧基，卤代（低级）烷氧基，硝基，氰基，氨基或酰氨基，R 3是氢或卤素，R 4是氢或低级烷基，R 5是氢或低级烷基，R 6是氢，羟基或低级烷基，R 7是氢或低级烷基，R 8是氢或卤素，R 9是羧基或酯化的羧基，A是低级亚烷基，条件是R 4较低烷基; R 5是低级烷基; R 6是羟基或低级烷基; 或R 8为卤素时，R 1为氢，R 2为卤素且R 3为氢，R 3为其药学上可接受的盐，其制备方法和包含其的药物组合物为卤素。

17. 发明申请

WO1983001515A1 ECHO DISPLAY UNIT FOR A PLURALITY OF SECTORS 审中-公开
标题翻译： ECHO显示单位为多个部门
公开(公告)号：WO1983001515A1
公开(公告)日：1983-04-28
申请号：PCT/JP1982000319
申请日：1982-08-16
申请人： KABUSHIKI KAISHA KODEN SEISAKUSHO , TANAKA, Isokazu , KATO, Takeshi , RYUGO, Shigeru , FUJII, Masahito , SUNAYAMA, Hirokazu
发明人： KABUSHIKI KAISHA KODEN SEISAKUSHO
IPC分类号： G01S15/42
CPC分类号： G01S7/6236 , G01S15/42
摘要： A sector scanning sonar can direct a transmitter/receiver (1) in a desired direction by turning means (2, 4, 201) and angle-of-depression setting means (3, 4, 301). Since the elements of the transmitter/receiver (1) are circularly arranged, it has been impossible to display the detected information in all circumferential directions with a sufficient intensity on a cathode ray display circuit. To eliminate this drawback, the detected information from all the circumferential directions concerning to the selected sector, distance, and azimuth is written in a main memory circuit (10), is controlled by an address control circuit (8), is stored temporarily, is controlled to correspond to the scanning format of raster scan type color display means (11, 13, 14) by an address control means (12), is repeatedly read, and is applied to the display means (11, 13, 14).
摘要翻译：扇形扫描声纳可以通过转动装置（2,4,1201）和倾角设定装置（3,4,1301）将发射器/接收器（1）沿所需方向引导。由于发送器/接收器（1）的元件是圆形布置的，所以不可能在阴极射线显示电路上以足够的强度在所有圆周方向上显示检测到的信息。为了消除这个缺点，来自与所选扇区，距离和方位角有关的所有圆周方向的检测信息被写入主存储器电路（10），由地址控制电路（8）控制，暂时存储，是通过地址控制装置（12）被控制为对应于光栅扫描型彩色显示装置（11,13,14）的扫描格式，被重复读取，并且被施加到显示装置（11,13,14）。

18. 发明申请

WO2013074719A3 LIQUID MOLDING RESIN WITH NONSWELLING MICA 审中-公开
标题翻译：液体模塑树脂与非保存MICA
公开(公告)号：WO2013074719A3
公开(公告)日：2014-12-04
申请号：PCT/US2012065157
申请日：2012-11-15
申请人： METTON AMERICA INC , MARUZEN PETROCHEM CO LTD , BABA HIROMITSU , KATO TAKESHI , MINAMI HIROYUKI , ABE MASANORI , YOKOO YUSUKE , WEST BEAU JEREMY
发明人： BABA HIROMITSU , KATO TAKESHI , MINAMI HIROYUKI , ABE MASANORI , YOKOO YUSUKE , WEST BEAU JEREMY
IPC分类号： B28B1/00
CPC分类号： B29C67/246 , B29K2023/38 , B29K2309/10
摘要： A liquid molding resin component for use in a reaction injection molding process includes a liquid resin reaction monomer including metathesis polymerizable cycloolefin and a plurality of nonswelling mica. The plurality of nonswelling mica have an average particle size in a range of about 35 micro m to about 500 micro m and have a bulk density in a range of about 0.10 g/ml to about 0.27 g/ml. Further, a liquid resin component system for use in a reaction injection molding process includes a plurality of liquid resin components that each include a reaction monomer including metathesis polymerizable cycloolefin. At least one of the liquid resin components includes a catalyst component of a metathesis polymerization catalyst system and at least one of the liquid resin components includes an activator component of a metathesis polymerization catalyst system.
摘要翻译：用于反应注射成型工艺的液体模塑树脂组分包括包含易位聚合环烯烃和多个非存在云母的液体树脂反应单体。多个非生物云母的平均粒度在约35微米至约500微米的范围内，堆积密度在约0.10克/毫升至约0.27克/毫升的范围内。此外，用于反应注射成型工艺的液体树脂组分系统包括多个液体树脂组分，每个液体树脂组分均包括含易位聚合性环烯烃的反应单体。至少一种液体树脂组分包括易位聚合催化剂体系的催化剂组分，并且至少一种液体树脂组分包括易位聚合催化剂体系的活化剂组分。

19. 发明申请

WO2004108686A2 BENZIMIDAZOLE COMPOUNDS 审中-公开
标题翻译：苯并咪唑化合物
公开(公告)号：WO2004108686A2
公开(公告)日：2004-12-16
申请号：PCT/JP2004/008064
申请日：2004-06-03
申请人： FUJISAWA PHARMACEUTICAL CO., LTD. , DAICEL CHEMICAL INDUSTRIES, LTD. , HAYASHIDA, Hisashi , HATANAKA, Keiko , KATO, Takeshi , KIDO, Yoshiyuki , TOMISHIMA, Masaki , KAYAKIRI, Hiroshi , TAKASE, Ichiro , HIRAMURA, Takahiro
发明人： HAYASHIDA, Hisashi , HATANAKA, Keiko , KATO, Takeshi , KIDO, Yoshiyuki , TOMISHIMA, Masaki , KAYAKIRI, Hiroshi , TAKASE, Ichiro , HIRAMURA, Takahiro
IPC分类号： C07D235/00
CPC分类号： C07D401/06 , C07D235/08 , C07D235/10 , C07D235/26 , C07D235/28 , C07D401/12 , C07D413/06 , C07D417/06
摘要： The present invention provides novel benzimidazole compounds of the formula (I): wherein each symbol is as defined in the specification, salts thereof and prodrugs thereof, which are useful in treating, for example, the diseases curable through decrease in blood sugar level.
摘要翻译：本发明提供新的式（I）的苯并咪唑化合物：其中每个符号如本说明书中所定义，其盐和前药，其可用于治疗例如通过降低血糖水平可治愈的疾病。

20. 发明申请

WO2003068768A1 IMIDAZOLE 4-CARBOXAMIDE COMPOUNDS WITH ADENOSINE DEAMINASE INHIBITING ACTIVITY 审中-公开
标题翻译：具有腺苷脱氨酶抑制活性的咪达唑-4-羧酰胺化合物
公开(公告)号：WO2003068768A1
公开(公告)日：2003-08-21
申请号：PCT/JP2003/001459
申请日：2003-02-12
申请人： FUJISAWA PHARMACEUTICAL Co., Ltd. , TSUJI, Kiyoshi , TERASAKA, Tadashi , KONISHI, Nobukiyo , KATO,Takeshi , NAKAMURA, Katsuya
发明人： TSUJI, Kiyoshi , TERASAKA, Tadashi , KONISHI, Nobukiyo , KATO,Takeshi , NAKAMURA, Katsuya
IPC分类号： C07D405/06
CPC分类号： C07D403/06 , C07D417/06
摘要： Imidazole compounds having adenosine deaminase inhibitory activity represented by the formula (I): wherein R 1 is optionally substituted aryl or optionally substituted heteroaryl, R 2 is lower alkyl; R 3 is hydroxy or protected hydroxy; X is 0 or S; and - A - is lower alkylene, its prodrug, or their salt. The compounds are useful for treating and/or preventing diseases for which adenosine is effective.
摘要翻译：具有由式（I）表示的腺苷脱氨酶抑制活性的咪唑化合物：其中R 1为任选取代的芳基或任选取代的杂芳基，R 2为低级烷基; R3是羟基或被保护的羟基; X为0或S; 和 - A - 是低级亚烷基，其前药或其盐。该化合物可用于治疗和/或预防腺苷有效的疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式